KRN321 (Darbepoetin alfa)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KRN321 (Darbepoetin alfa), covering 2012-08-31 to 2012-08-31. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor [Phase 2]